This review demonstrates the role of mass spectrometry in analyzing metabolites from gut microbiota, indicating their impact on health and disease.
Gut microbiota produces a wide range of metabolites and plays a critical role in maintaining host health. Dysregulation of these metabolites can influence host metabolism through systemic circulation, contributing to the development of various diseases, including immunological, neurological and cancer-related disorders. Chromatography coupled with mass spectrometry (MS) has emerged as a powerful analytical approach, offering high sensitivity and resolution for studying gut microbiota-related metabolites. This review provides a comprehensive overview of chromatographic MS-based methods applied to the study of the gut microbial metabolome. We summarize strategies for sample collection, storage, and preparation of commonly analyzed sample types, including feces, plasma/serum, urine, and tissue samples. In addition, we included the main chromatographic MS-based approaches, as well as data analysis techniques, for investigating the gut microbial metabolome. The characteristics and utility of liquid chromatographic-mass spectrometry (LC-MS), gas chromatographic-mass spectrometry (GC-MS), and capillary electrophoresis-mass spectrometry (CE-MS) were discussed in the context of providing broader coverage of gut microbiota-derived metabolites with diverse physicochemical properties. Finally, we summarize recent studies that have employed chromatographic MS-based approaches to investigate gut microbiota-related disease. Through the integration of appropriate sample handling and advanced analytical strategies, a deeper understanding of host–microbiota interactions and their roles in health and disease can be achieved.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: